The burgeoning science of genetics and the impact on public policy.
The legislative branch of government often wrestles with the challenges of public policy issues in the health care area that raise multi-dimensional questions that cut across disciplines of science, law, economics, and ethics. Sometimes the purely scientific issues can be confounding by themselves. This article highlights some key policy issues that require consideration in the post-genome era.
Hatch
Orrin G
OG
United States Senate, USA.
D001709:Biotechnology / Q000331:legislation & jurisprudence*; D023482:Bioterrorism / Q000517:prevention & control; D016172:DNA Fingerprinting / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D033041:Embryo Research; D035082:Federal Government; D030661:Genetic Privacy / Q000331:legislation & jurisprudence; D036281:Genetic Research; D006801:Humans; D007883:Legislation, Medical; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D011640:Public Policy; D013234:Stem Cells; D014481:United States